Nuclear Uptake of l,25‐Dihydroxy[3H]‐cholecalciferol in Peripheral Blood Monocytes

The active vitamin D metabolite, 1,25‐dihydroxycholecal ciferol induces differentiation of monocytes into macrophages. The pharmacological induction of differentiation of primitive, rapidly proliferating cell lines into more mature cells with lower proliferative potential is a new dimension in the treatment of myeloproliferative disorders, which may prove to be an important alternative to more traditional regimens, Furthermore, the cell primarily engaged in bone resorption‐the osteoclast‐represents another differentiated form of mononuclear phagocytes, and 1,25‐dihydroxycholecalciferol increases the number of osteoclasts. Since the cellular action of 1,25‐dihydroxycholecalciferol is exerted mainly through its binding to nuclear receptors, a detailed knowledge of ligand‐receptor interactions is mandatory for future work in this area. In order to investigate the interaction between 1,25‐dihydroxycholecalciferol and its receptor in mononuclear cells, the nuclear uptake of the hormone was studied using a whole cell assay. The nuclear uptake of l,25‐dihydroxy[3H]cholecalciferol in human monocytes at physiological temperature and pH was saturable, specific, and fully reversible. When eight normal individuals were investigated, the maximal binding capacity (Bmax) was 0.4–8.4 fmol/106 cells and the dissociation constants (Kd) were 0.12–0.45 nmol/l. The characterization of the nuclear uptake of 1,25‐dihydroxy [3H]cholecalciferol in intact human monocytes shows that it is mediated by binding of the ligand to a specific nuclear receptor. The binding to the nuclear receptor is the result of the passage of ligand across the cytoplasmic membrane and of the cytoplasmic transport of ligand. In contrast to conventional receptor assays in hypertonic cellular extracts, this system provides information on the role of the cytoplasmic membrane in relation to the nuclear uptake of 1,25‐dihydroxycholecalciferol, which may be closer to in vivo cellular conditions.

[1]  H. DeLuca,et al.  Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. , 1984, Cancer research.

[2]  M. Fanger,et al.  Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis , 1984 .

[3]  F. Melsen,et al.  Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. , 1984, Metabolic bone disease & related research.

[4]  S. Krane,et al.  Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. , 1983, The Journal of clinical endocrinology and metabolism.

[5]  H. Koeffler Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications , 1983 .

[6]  B. Kream,et al.  Regulation of bone formation. , 1983, The New England journal of medicine.

[7]  E H Burger,et al.  In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes , 1982, The Journal of experimental medicine.

[8]  C. Jacobsen,et al.  Determination of affinity of monoclonal antibodies against human IgG. , 1982, Journal of immunological methods.

[9]  S. Marx,et al.  Nuclear uptake of 1,25-dihydroxy[3H]cholecalciferol in dispersed fibroblasts cultured from normal human skin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Norman,et al.  Apparent nuclear localization of unoccupied receptors for 1,25-dihydroxyvitamin D3. , 1981, Biochemical and biophysical research communications.

[11]  M. Haussler,et al.  Physiological importance of vitamin D metabolism. , 1980, Progress in biochemical pharmacology.

[12]  C. Mundy,et al.  Direct resorption of bone by human monocytes. , 1977, Science.

[13]  M. García-Rodríguez,et al.  DEFECTIVE NEUTROPHIL MOTILITY IN HYPOVITAMINOSIS D RICKETS , 1976 .

[14]  M. García-Rodríguez,et al.  DEFECTIVE NEUTROPHIL MOTILITY IN HYPOVITAMINOSIS D RICKETS , 1976, Acta paediatrica Scandinavica.